Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In addition, it offers containers and plastic products. The company was founded in 1952 and is headquartered in Taipei, Taiwan.
Metrics to compare | 3716 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship3716PeersSector | |
---|---|---|---|---|
P/E Ratio | 15.0x | 0.0x | −0.5x | |
PEG Ratio | −1.77 | 0.00 | 0.00 | |
Price/Book | 0.7x | 0.0x | 2.6x | |
Price / LTM Sales | 0.6x | 0.0x | 3.2x | |
Upside (Analyst Target) | - | 0.0% | 41.2% | |
Fair Value Upside | Unlock | 0.0% | 6.2% | Unlock |